Five Year Outcomes for MDD and Psilocybin

 Persistent depression that won’t lift? There’s promising new research from the Journal of Psychedelic Studies (2025).

A 5-year follow-up study tracked 24 participants with major depressive disorder who received two guided psilocybin sessions with therapy. The results are striking:

67% were in remission after five years

79% reported lasting symptom improvement

Only 17% still relied on traditional antidepressants

This isn’t just a temporary boost—it shows long-term change under professional guidance. Participants also reported reduced anxiety, improved emotional resilience, and better daily functioning.

✅ Safe and carefully administered by licensed facilitators

✅ Evidence-backed, transformative mental health support

Read more here:

https://akjournals.com/configurable/content/journals$002f2054$002f9$002f4$002farticle-p320.xml?t:ac=journals%24002f2054%24002f9%24002f4%24002farticle-p320.xml